LB Pharmaceuticals (LBRX) announced the appointment of James Rawls, Pharm.D., as Senior Vice President, SVP, of Regulatory Affairs. Rawls joins LB Pharmaceuticals from Boston Biodevelopment, where he served as Executive Vice President and Chief Regulatory Officer
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LBRX:
- Opening Day: Cerebras Systems withdraws IPO filing
- Buy Rating for LB Pharmaceuticals Driven by Promising LB-102 and Market Potential
- LB Pharmaceuticals to present posters on Phase 2 NOVA trial of LB-102
- LB Pharmaceuticals initiated with an Outperform at Leerink
- LB Pharmaceuticals initiated with a Buy at Stifel